While TF alone may have limited diagnostic value, its effectiveness improves when combined with other markers such as CA‐125, apolipoprotein A‐I, and transthyretin for early ovarian cancer detection [73, 74]. This evidence concerns the gene TTR and ovarian carcinoma.